Shrewsbury R P, White S G, Pollack G M, Wargin W A
J Pharm Pharmacol. 1986 Dec;38(12):883-7. doi: 10.1111/j.2042-7158.1986.tb03376.x.
The effects of partial blood exchange with Fluosol-DA on hepatic microsomal oxidative metabolism have been studied in the rat. Antipyrine clearance (Cl) was used as an in-vivo measure of the activity of the mixed function oxidase system. Rats were partially exchanged with Fluosol-DA and dosed with antipyrine at selected time intervals following exchange. No change in antipyrine Cl was observed at 0.5 h, but there was a statistically significant decrease at 24 h and then an increase by more than 50% relative to control at 48 and 72 h. These data indicate that the effects of Fluosol-DA on hepatic function are time-dependent and that Fluosol-DA has the potential both to inhibit and to enhance hepatic metabolism. The possibility of altered hepatic metabolism should be considered when patients transfused with Fluosol-DA are given drugs primarily metabolized by the mixed function oxidase system.
在大鼠中研究了用氟碳代血液(Fluosol-DA)进行部分血液交换对肝微粒体氧化代谢的影响。安替比林清除率(Cl)被用作混合功能氧化酶系统活性的体内测量指标。大鼠用氟碳代血液(Fluosol-DA)进行部分血液交换,并在交换后的选定时间间隔给予安替比林。在0.5小时时未观察到安替比林清除率的变化,但在24小时时有统计学上的显著下降,然后在48小时和72小时时相对于对照组增加超过50%。这些数据表明氟碳代血液(Fluosol-DA)对肝功能的影响是时间依赖性的,并且氟碳代血液(Fluosol-DA)具有抑制和增强肝代谢的潜力。当给输注氟碳代血液(Fluosol-DA)的患者使用主要由混合功能氧化酶系统代谢的药物时,应考虑肝代谢改变的可能性。